---
layout: minimal-medicine
title: Vinflunine
---

# Vinflunine
### Generic Name
Vinflunine

### Usage
Vinflunine is a chemotherapy medication primarily used to treat advanced or metastatic transitional-cell carcinoma of the urothelial tract.  This means it's used in patients whose cancer has spread and who haven't responded well to treatment with platinum-based chemotherapy drugs.  It's a second-line treatment option, meaning it's used after other treatments have failed.  Currently, there are no other notable secondary uses approved.

### Dosage

**Adult Dosage (Urothelial Cell Carcinoma):** Vinflunine is administered intravenously (IV).  The usual starting dose is 320 mg/m² once every three weeks. However, dose adjustments are crucial and depend on several factors:

* **Age:** Patients aged 75 to less than 80 years receive a reduced initial dose of 280 mg/m². For those 80 years and older, the initial dose is further reduced to 250 mg/m².  Patients younger than 75 typically don't require age-based adjustments.
* **Performance Status:**  Patients with a World Health Organization (WHO) performance status (PS) of 1, or those with a PS of 0 who have received prior pelvic radiation, begin with a lower dose of 280 mg/m². If tolerated, the dose may increase to 320 mg/m² in subsequent cycles.  Vinflunine's efficacy and safety haven't been studied in patients with a PS of 2.
* **Hepatic Impairment:** Dose adjustments are necessary for patients with liver problems (hepatic impairment), based on the severity as assessed by Child-Pugh score and liver function tests.  Specific dosage reductions are outlined in the prescribing information.  Severe impairment may preclude the use of Vinflunine.
* **Renal Impairment:** Dose adjustments are also needed for patients with kidney problems (renal impairment), based on creatinine clearance (CrCl).  Lower CrCl values necessitate dose reductions, and Vinflunine use may be contraindicated with very low CrCl.
* **Obesity:**  Current guidelines recommend using actual body weight for dosage calculations based on body surface area (BSA) in obese patients, adjusting for toxicity as needed.

**Pediatric Dosage:** Vinflunine is not approved for use in children and adolescents.


**Administration:** Vinflunine is infused intravenously over 20 minutes. It's usually administered through a central line or a vein in the upper arm, avoiding veins in the hand or near joints. To prevent constipation, laxatives and increased fluid intake are recommended for several days following each dose.  Extravasation (leakage from the vein) requires immediate discontinuation of the infusion and administration of hyaluronidase.

### Side Effects

**Common Side Effects (occurring in >10% of patients):**

* Fatigue
* Peripheral sensory neuropathy (numbness, tingling, or pain in the extremities)
* Constipation
* Nausea
* Anorexia (loss of appetite)
* Stomatitis (mouth sores)
* Vomiting
* Abdominal pain
* Diarrhea
* Alopecia (hair loss)
* Anemia
* Leukopenia (low white blood cell count)
* Neutropenia (low neutrophil count – a type of white blood cell)
* Thrombocytopenia (low platelet count)
* Weakness
* Myalgia (muscle pain)
* Venous irritation
* Injection-site reaction
* Hyponatremia (low sodium levels)
* Weight loss
* Fever


**Less Common but Serious Side Effects:**  These occur in a smaller percentage of patients but can be life-threatening.  Immediate medical attention is necessary if these occur:

* Severe neutropenia with fever (neutropenic fever)
* Severe constipation requiring medical intervention
* Severe neuropathy
* Cardiac ischemia (reduced blood flow to the heart)
* Severe mucositis (inflammation of the mucous membranes)
* Other grade 3 or higher toxicities (as defined by the Common Terminology Criteria for Adverse Events [CTCAE])
* Hypersensitivity reactions
* Posterior reversible encephalopathy syndrome (PRES)
* Syndrome of inappropriate antidiuretic hormone secretion (SIADH)


A healthcare provider should be consulted immediately if any concerning side effects develop.

### How it Works

Vinflunine is a vinca alkaloid, a type of chemotherapy drug. It works by binding to tubulin, a protein that forms microtubules. Microtubules are essential components of cells, playing a crucial role in cell division. By binding to tubulin, Vinflunine prevents microtubules from forming correctly, which interferes with cell division and ultimately leads to the death of cancer cells (apoptosis).

### Precautions

**Contraindications:** Vinflunine is contraindicated (should not be used) in patients with:

* Hypersensitivity to Vinflunine or other vinca alkaloids.
* Severe infection.
* Low white blood cell counts (ANC <1500/mm³ for the first dose or <1000/mm³ for subsequent doses).
* Low platelet counts (<100,000/mm³).
* Breastfeeding.


**Warnings and Precautions:**

* **Hematologic Toxicity:**  Vinflunine can significantly lower blood cell counts, increasing the risk of infections and bleeding.  Regular blood tests are crucial to monitor this.
* **Gastrointestinal Effects:**  Constipation is a common and potentially serious side effect.  Preventive measures are essential.
* **Neurotoxicity:** Vinflunine can cause nerve damage (peripheral neuropathy), potentially leading to weakness, numbness, and pain.
* **Electrolyte Imbalances:**  Vinflunine can cause low sodium levels (hyponatremia).
* **Cardiac Effects:**  Vinflunine may prolong the QT interval on an electrocardiogram (ECG), increasing the risk of dangerous heart rhythms, especially in patients with pre-existing heart conditions.
* **Pregnancy and Lactation:** Vinflunine is categorized as pregnancy category D, meaning it poses a risk to the fetus.  Effective contraception is mandatory for women of reproductive age. Breastfeeding is contraindicated.
* **Drug Interactions:** Vinflunine can interact with other medications, especially those metabolized by the CYP3A4 enzyme or those that prolong the QT interval.  Discussions with a healthcare professional about all medications are essential.
* **Elderly Patients:**  Older adults may be more susceptible to the side effects of Vinflunine.  Dose adjustments are often necessary.


### FAQs

* **Q: How long will I need to take Vinflunine?** A: The duration of treatment depends on your response to the medication and your overall health. Your doctor will determine the appropriate treatment length.

* **Q: How is Vinflunine stored?** A: Store Vinflunine as directed by your pharmacist or doctor, typically at a controlled room temperature, away from light and moisture.

* **Q: What should I do if I miss a dose?** A: Contact your doctor or healthcare provider immediately if you miss a dose.  Do not attempt to make up for a missed dose without guidance.

* **Q: Can I drive or operate machinery while on Vinflunine?** A:  Due to potential side effects like fatigue and neuropathy, it's crucial to assess your ability to safely operate machinery or drive.  Follow your doctor's advice.

* **Q: Are there any long-term effects of Vinflunine?** A:  While Vinflunine is effective, like many chemotherapy drugs, it has potential long-term side effects. Regular monitoring and follow-up care are essential to detect and manage any issues.


**Disclaimer:** This information is for educational purposes only and should not be considered medical advice.  Always consult a healthcare professional for diagnosis and treatment of any medical condition.  The provided dosage and other information may not be exhaustive and should be verified with the most current prescribing information.
